AI assistant
DEXCOM INC — Director's Dealing 2016
May 26, 2016
30198_dirs_2016-05-26_136b053e-0c1e-419a-aaca-802c1061e046.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-05-25
Reporting Person: ALTMAN STEVEN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-25 | Common Stock | A | 4791.0 | $0.0010 | Acquired | 12639 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14363 | Indirect |
Footnotes
F1: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2: Included in this number are 12,639 unvested restricted stock units, 4,791 of which were granted on May 25, 2016 and shall vest on May 25, 2017, 4,279 of which were granted on June 3, 2015 and shall vest on June 3, 2016 and 3,569 of which were granted on November 4, 2013 and shall vest on November 4, 2016.
F3: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.